A citation-based method for searching scientific literature

Bingshu Wu, Hongzhi Zheng, Jianqiu Gu, Yan Guo, Yixuan Liu, Yingfang Wang, Feng Chen, Aolin Yang, Jiabei Wang, Hailong Wang, Ying Liu, Difei Wang. J Diabetes Investig 2019
Times Cited: 3







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial.
Julio Rosenstock, Alice Cheng, Robert Ritzel, Zsolt Bosnyak, Christine Devisme, Anna M G Cali, Jochen Sieber, Peter Stella, Xiangling Wang, Juan P Frías,[...]. Diabetes Care 2018
76
66

Addition of dipeptidyl peptidase-4 inhibitors to insulin treatment in type 2 diabetes patients: A meta-analysis.
Wenjia Yang, Xiaoling Cai, Xueying Gao, Yifei Chen, Ling Chen, Linong Ji. J Diabetes Investig 2018
13
66

Efficacy and Renal Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus Also Receiving Metformin: A Real-Life Experience.
Alessandro Scorsone, Gabriella Saura, Mattia Fleres, Lucia Spano, Vito Aiello, Davide Brancato, Anna Di Noto, Francesca Provenzano, Vincenzo Provenzano. J Diabetes Res 2018
2
50

Chronic hyperuricemia, uric acid deposit and cardiovascular risk.
Davide Grassi, Livia Ferri, Giovambattista Desideri, Paolo Di Giosia, Paola Cheli, Rita Del Pinto, Giuliana Properzi, Claudio Ferri. Curr Pharm Des 2013
90
33

Renal transport of uric acid: evolving concepts and uncertainties.
Ion Alexandru Bobulescu, Orson W Moe. Adv Chronic Kidney Dis 2012
148
33

The effects of intermittent use of the SGLT-2 inhibitor, dapagliflozin, in overweight patients with type 2 diabetes in Japan: a randomized, crossover, controlled clinical trial.
Kanako Kato, Kunihiro Suzuki, Chie Aoki, Masaaki Sagara, Takafumi Niitani, Sho Wakamatsu, Kazunori Yanagi, Yoshimasa Aso. Expert Opin Pharmacother 2017
4
33

Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus.
Michiaki Fukui, Muhei Tanaka, Emi Shiraishi, Ichiko Harusato, Hiroko Hosoda, Mai Asano, Mayuko Kadono, Goji Hasegawa, Toshikazu Yoshikawa, Naoto Nakamura. Metabolism 2008
75
33


Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16-week double-blind treatment period.
Eiichi Araki, Yukiko Onishi, Michiko Asano, Hyosung Kim, Ella Ekholm, Eva Johnsson, Toshitaka Yajima. J Diabetes Investig 2016
31
33

Management of diabetes and hyperglycemia in hospitals.
Stephen Clement, Susan S Braithwaite, Michelle F Magee, Andrew Ahmann, Elizabeth P Smith, Rebecca G Schafer, Irl B Hirsch. Diabetes Care 2004
653
33

Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial.
Clifford J Bailey, Jorge L Gross, Delphine Hennicken, Nayyar Iqbal, Traci A Mansfield, James F List. BMC Med 2013
170
33

Temporal relationship between uric acid concentration and risk of diabetes in a community-based study population.
Stephen P Juraschek, Mara McAdams-Demarco, Edgar R Miller, Allan C Gelber, Janet W Maynard, James S Pankow, Hunter Young, Josef Coresh, Elizabeth Selvin. Am J Epidemiol 2014
39
33


Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial.
Michael A Nauck, Stefano Del Prato, Juris J Meier, Santiago Durán-García, Katja Rohwedder, Martina Elze, Shamik J Parikh. Diabetes Care 2011
328
33

Serum uric acid levels and the risk of type 2 diabetes: a prospective study.
Vidula Bhole, Jee Woong J Choi, Sung Woo Kim, Mary de Vera, Hyon Choi. Am J Med 2010
139
33

Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey, 1999-2006.
Lauren F Loeffler, Ana Navas-Acien, Tammy M Brady, Edgar R Miller, Jeffrey J Fadrowski. Hypertension 2012
102
33

Dapagliflozin for the treatment of type 2 diabetes.
Muhammad A Abdul-Ghani, Ralph A DeFronzo. Expert Opin Pharmacother 2013
12
33

Diabetes and hyperglycemia quality improvement efforts in hospitals in the United States: current status, practice variation, and barriers to implementation.
Curtiss B Cook, Beth Elias, Gail L Kongable, Daniel J Potter, Katherine M Shepherd, David McMahon. Endocr Pract 2010
39
33


Temporal relationship between hyperuricemia and obesity, and its association with future risk of type 2 diabetes.
Tianshu Han, Xing Meng, Ruiqi Shan, Tianqi Zi, Yingmei Li, Hao Ma, Yanhe Zhao, Dan Shi, Rongge Qu, Xiaoyu Guo,[...]. Int J Obes (Lond) 2018
12
33

Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes.
Qin Li, Zhen Yang, Bin Lu, Jie Wen, Zi Ye, Lili Chen, Min He, Xiaoming Tao, Weiwei Zhang, Ying Huang,[...]. Cardiovasc Diabetol 2011
80
33

The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts.
Siguang Li, Serena Sanna, Andrea Maschio, Fabio Busonero, Gianluca Usala, Antonella Mulas, Sandra Lai, Mariano Dei, Marco Orrù, Giuseppe Albai,[...]. PLoS Genet 2007
190
33

Serum Uric Acid Levels and Diabetic Peripheral Neuropathy in Type 2 Diabetes: a Systematic Review and Meta-analysis.
Shuai Yu, Ying Chen, Xu Hou, Donghua Xu, Kui Che, Changgui Li, Shengli Yan, Yangang Wang, Bin Wang. Mol Neurobiol 2016
16
33

Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on serum uric acid level: A meta-analysis of randomized controlled trials.
Yumo Zhao, Lubin Xu, Dongli Tian, Peng Xia, Hua Zheng, Li Wang, Limeng Chen. Diabetes Obes Metab 2018
76
33

Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study.
Eswar Krishnan, Bhavik J Pandya, Lorinda Chung, Ali Hariri, Omar Dabbous. Am J Epidemiol 2012
120
33

Association between uric acid, cancer incidence and mortality in patients with type 2 diabetes: Shanghai diabetes registry study.
Zixuan Deng, Yunjuan Gu, Xuhong Hou, Lei Zhang, Yuqian Bao, Cheng Hu, Weiping Jia. Diabetes Metab Res Rev 2016
13
33

Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes.
James F List, Vincent Woo, Enrique Morales, Weihua Tang, Fred T Fiedorek. Diabetes Care 2009
410
33


Twice-daily dapagliflozin co-administered with metformin in type 2 diabetes: a 16-week randomized, placebo-controlled clinical trial.
P-M Schumm-Draeger, L Burgess, L Korányi, V Hruba, J E Hamer-Maansson, T W A de Bruin. Diabetes Obes Metab 2015
31
33

Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.
Seo Young Kim, James P Guevara, Kyoung Mi Kim, Hyon K Choi, Daniel F Heitjan, Daniel A Albert. Arthritis Care Res (Hoboken) 2010
346
33

Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus.
Filippo Valbusa, Lorenzo Bertolini, Stefano Bonapace, Luciano Zenari, Giacomo Zoppini, Guido Arcaro, Christopher D Byrne, Giovanni Targher. Am J Cardiol 2013
43
33

Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial.
John P H Wilding, Vincent Woo, Norman G Soler, Andrea Pahor, Jennifer Sugg, Katja Rohwedder, Shamik Parikh. Ann Intern Med 2012
283
33

Uric acid is an important predictor for hypertensive early atherosclerosis.
Ruya Mutluay, Serpil Muge Deger, Eylem Bahadir, Alim Ozgur Durmaz, Riza Citil, Sukru Sindel. Adv Ther 2012
18
33


Plasma uric acid and the risk of type 2 diabetes in a Chinese community.
Kuo-Liong Chien, Ming-Fong Chen, Hsiu-Ching Hsu, Wei-Tien Chang, Ta-Chen Su, Yuan-Teh Lee, Frank B Hu. Clin Chem 2008
94
33


[Main causes of hyperuricemia in diabetes mellitus].
I V Madianov, M I Balabolkin, D S Markov, T N Markova. Ter Arkh 2000
15
33

SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria.
Yukihiro Chino, Yoshishige Samukawa, Soichi Sakai, Yasuhiro Nakai, Jun-ichi Yamaguchi, Takeo Nakanishi, Ikumi Tamai. Biopharm Drug Dispos 2014
132
33




Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review.
Kamlesh Khunti, Marilia B Gomes, Stuart Pocock, Marina V Shestakova, Stéphane Pintat, Peter Fenici, Niklas Hammar, Jesús Medina. Diabetes Obes Metab 2018
83
33

Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetologia 2018
410
33



Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis.
M Monami, C Lamanna, N Marchionni, E Mannucci. Exp Clin Endocrinol Diabetes 2009
24
33

Analyte-Responsive Hydrogels: Intelligent Materials for Biosensing and Drug Delivery.
Heidi R Culver, John R Clegg, Nicholas A Peppas. Acc Chem Res 2017
99
33

Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naïve Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Agents.
Julio Rosenstock, Denise Franco, Vadym Korpachev, Brad Shumel, Yuhui Ma, Robert Baughman, Nikhil Amin, Janet B McGill. Diabetes Care 2015
18
33


Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis.
Jorge L Gross, Caroline K Kramer, Cristiane B Leitão, Neil Hawkins, Luciana V Viana, Beatriz D Schaan, Lana C Pinto, Ticiana C Rodrigues, Mirela J Azevedo. Ann Intern Med 2011
91
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.